Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Olafsdottir, Elinborg J
van Grieken, Nicole C T
Moller, Pall H
Meijer, Gerrit A
Jonasson, Jon G
MetadataShow full item record
CitationWhy is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years. 2017, 141 (3):531-539 Int. J. Cancer
AbstractThere is limited information present to explain temporal improvements in colon cancer survival. This nationwide study investigates the temporal changes in survival over a 35-year period (1970-2004) in Iceland and uses incidence, mortality, surgery rate, stage distribution, lymph node yield, tumor location and histological type to find explanations for these changes. Patients diagnosed with colon cancer in Iceland 1970-2004 were identified (n = 1962). All histopathology was reassessed. Proportions, age-standardized incidence and mortality, relative, cancer-specific and overall survival and conditional survival were calculated. When comparing first and last diagnostic periods (1970-1978 and 1997-2004), 5-year relative survival improved by 12% for men and 9% for women. At the same time surgery rate increased by 12% and the proportion of stage I increased by 9%. Stage-stratified, improved 5-year relative survival was mainly observed in stages II and III and coincided with higher lymph node yields, proportional reduction of stage II cancers and proportional increase of stage III cancers, indicating stage migration between these stages. Improvement in 1-year survival was mainly observed in stages III and IV. Five-year survival improvement for patients living beyond 1 year was minimum to none. There were no changes in histology that coincided with neither increased incidence nor possibly influencing improved survival. Concluding, as a novel finding, 1-year mortality, which previously has been identified as an important variable in explaining international survival differences, is in this study identified as also being important in explaining temporal improvements in colon cancer survival in Iceland.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
RightsArchived with thanks to International journal of cancer
- pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited.
- Authors: Snaebjornsson P, Coupe VM, Jonasson L, Meijer GA, van Grieken NC, Jonasson JG
- Issue date: 2014 Jul 15
- [Colon cancer in Iceland 1955-2004. Study on epidemiology, histopathology and gender difference].
- Authors: Snaebjörnsson P, Jónasson L, Jónsson T, Möller PH, Theodórs A, Jónasson JG
- Issue date: 2009 Jun
- Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study.
- Authors: Vather R, Sammour T, Kahokehr A, Connolly AB, Hill AG
- Issue date: 2009 Mar
- Colon cancer in Luxembourg: a national population-based data report, 1988-1998.
- Authors: Scheiden R, Pescatore P, Wagener Y, Kieffer N, Capesius C
- Issue date: 2005 May 24
- The relation between lymph node status and survival in Stage I-III colon cancer: results from a prospective nationwide cohort study.
- Authors: Lykke J, Roikjaer O, Jess P, Danish Colorectal Cancer Group.
- Issue date: 2013 May